comparemela.com

Page 11 - Agilex Biolabs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Agilex Biolabs Partners with Endpoints News on Deconvoluting Inflammation and Immunology for Clinical Trials

Agilex Biolabs Partners with Endpoints News on Deconvoluting Inflammation and Immunology for Clinical Trials ADELAIDE, AUS, May 21, 2021 - (ACN Newswire) - Agilex Biolabs, Australia s largest and most technologically advanced specialist bioanalytical laboratory for clinical trials is partnering with Endpoints News to share the latest on deconvoluting inflammation and immunology for clinical trials, in a webinar hosted by Endpoints News Editor Arsalan Arif. Agilex Biolabs Director, Immunoassay, Kurt J. Sales (B.Sc; B.Sc (MED) Hons; M.Sc, Ph.D, PGCM) said: Inflammation is a complex biological process involving a host of resident and recruited immune cells which are mobilized to infiltrate tissues in response to invading pathogens. These immune cells boast elevated numbers and heightened activation as they churn out inflammatory mediators, which act in unison to coordinate and modulate the immune response. Choosing the right bioanalytical platform for your immunology clinical trial

Agilex Biolabs Partners with Endpoints News on Deconvoluting Inflammation

Agilex Biolabs Toxicology Tapped for SARS-CoV-2 Vaccine Research

Agilex Biolabs Toxicology Tapped for SARS-CoV-2 Vaccine Research Agilex Biolabs said biotechs with first-in-human studies can leverage significant quality, speed and cost advantages working with their company TetraQ toxicology for pre-clinical research in Australia. BriefingWire.com, 5/17/2021 - ADELAIDE, AUS, May 17, 2021 - (ACN Newswire) - Agilex Biolabs, Australia s largest and most technologically advanced specialist bioanalytical laboratory for clinical trials, said biotechs with first-in-human studies can leverage significant quality, speed and cost advantages working with their company TetraQ toxicology for pre-clinical research in Australia. TetraQ is a NATA-accredited, GLP-recognised rodent toxicology facility. The TetraQ toxicology team, whose recent COVID-19 vaccine work is featured in PubMed, is one of the most experienced in the region with more than 15 years of success with biotechs and university researchers. In a

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.